Overview
Hemolytic anemia of pregnancy can be caused by alloimmunization, such as anti-Cartwright (Yta) antibodies, leading to shortened red blood cell survival and potential hemolysis 1.Diagnosis
Serum testing: Identify presence of anti-Cartwright (Yta) antibodies 1.
51Cr-labeled red cell survival study: Assess red cell survival to determine compatibility with transfusions 1.
Adverse reactions monitoring: Evaluate for adverse reactions during transfusions of Yta-positive cells 1.Management
Red cell transfusion: Use Yta-negative red cells if survival studies indicate incompatibility; otherwise, Yta-positive cells may be safe 1.
Survival studies: Perform 1-hour 51Cr-labeled red cell survival tests to guide transfusion decisions 1.Special Populations
Pregnancy: Specific management guided by red cell survival studies to balance transfusion safety and blood conservation 1.Key Recommendations
Perform a 1-hour 51Cr-labeled red cell survival study when feasible to determine compatibility with Yta-positive red cells 1 (Evidence: Moderate).
Use Yta-negative red cells if survival studies show increased destruction of Yta-positive cells to prevent hemolysis 1 (Evidence: Moderate).
Consider Yta-positive red cells safe in cases without adverse reactions and with high survival rates 1 (Evidence: Weak).References
1 Mohandas K, Spivack M, Delehanty CL. Management of patients with anti-Cartwright (Yta). Transfusion 1985. link